secwatch.observer — SEC 8-K summary
======================================

Issuer:     Profound Medical Corp. (PROF)
CIK:        0001628808
Form:       8-K
Filed at:   2026-05-07T23:59:59+00:00
Accession:  0001171843-26-003160
Event type: earnings
Sentiment:  positive
Materiality: 0.90
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud

Profound Medical Reports Strong Q1 2026 Results with 104% Revenue Growth and Humana Coverage
--------------------------------------------------------------------------------

- Revenue grew 104% year-over-year to $5.3M, with $2.5M recurring and $2.9M capital equipment.
- Net loss improved 34% to $7.0M ($0.19 per share) from $10.7M in Q1 2025.
- Humana became first national U.S. payor to cover the TULSA Procedure, adding ~8.5M covered lives.
- CAPTAIN trial met primary safety endpoint; TULSA INDEX20 average procedures per quarter rose to 11.3.
- Full-year 2026 revenue guidance set at ~$25M, representing 56% growth over prior year.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326003160/0001171843-26-003160-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1628808/000117184326003160/f8k_050726.htm
  HTML page:      https://secwatch.observer/filing/0001171843-26-003160

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer